Grant: Collaborative Health Research Projects (NSERC partnered)
McGill University
$163,222.00
Novel multilayered synthetic structural bone graft materials which combine biocompatibility, biodegradability and high toughness.
EF 2016-17
Résumé
Due to the ageing world population, techniques to replace, restore, or regenerate bone have become a major clinical need in the fields of orthopaedic, spinal, dental, cranial, and maxillofacial surgery. For these patients that suffer from bone loss and bone defects, surgical treatment remains a major challenge. Traditional bone grafting techniques have performance limitations including donor site morbidity, viral transmission, immunologic incompatibility, long rehabilitation time and structural failure. The need for new strategies for the treatment of bone defects is therefore urgent. The ideal bone graft material must: (i) match the mechanical properties of healthy bone; (ii) be biocompatible and promote healing and (iii) must degrade over time to be replaced by healthy bone. To this day, there is no synthetic material that can fulfill these three requirements simultaneously. In this project we will develop a new structural bone graft made from calcium sulfate, collagen and gelatin. All components of this material are fully biocompatible and FDA-approved for use as biomaterials. The mineral content provides stiffness, while the weaker protein layers can deflect incoming cracks to generate toughness. The implication is that this material can be used to fabricate load-carrying grafts, as opposed to traditional calcium phosphates/sulfates which are too brittle. The structural bone graft can be of varying sizes and dimensions. In-vivo performance will be evaluated with an animal study. In addition, bone grafts with complex patient-specific shapes will be developed using 3D printed polymeric templates. This new medical technology will have a significant impact on restoring functionality and quality of life in patients requiring reconstruction of structural bone defects secondary to trauma, failed arthroplasties, bone tumors, maxillofacial surgery or other bone diseases.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
361100
Name
Barthelat Francois
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Novel multilayered synthetic structural bone graft materials which combine biocompatibility, biodegradability and high toughness.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$163,222
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Biocompatibility; Bone Graft; Calcium Sulphate; Collagen; Fracture Toughness; Load-Bearing Implants; Multilayered Materials; Segmental Defects
Abstract
Due to the ageing world population, techniques to replace, restore, or regenerate bone have become a major clinical need in the fields of orthopaedic, spinal, dental, cranial, and maxillofacial surgery. For these patients that suffer from bone loss and bone defects, surgical treatment remains a major challenge. Traditional bone grafting techniques have performance limitations including donor site morbidity, viral transmission, immunologic incompatibility, long rehabilitation time and structural failure. The need for new strategies for the treatment of bone defects is therefore urgent. The ideal bone graft material must: (i) match the mechanical properties of healthy bone; (ii) be biocompatible and promote healing and (iii) must degrade over time to be replaced by healthy bone. To this day, there is no synthetic material that can fulfill these three requirements simultaneously. In this project we will develop a new structural bone graft made from calcium sulfate, collagen and gelatin. All components of this material are fully biocompatible and FDA-approved for use as biomaterials. The mineral content provides stiffness, while the weaker protein layers can deflect incoming cracks to generate toughness. The implication is that this material can be used to fabricate load-carrying grafts, as opposed to traditional calcium phosphates/sulfates which are too brittle. The structural bone graft can be of varying sizes and dimensions. In-vivo performance will be evaluated with an animal study. In addition, bone grafts with complex patient-specific shapes will be developed using 3D printed polymeric templates. This new medical technology will have a significant impact on restoring functionality and quality of life in patients requiring reconstruction of structural bone defects secondary to trauma, failed arthroplasties, bone tumors, maxillofacial surgery or other bone diseases.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Barthelat, Francois; Tanzer, Michael
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $163,222~ $0~